ICV injection of an ASO targeting the mRNA of brain-expressed GYS1 in a murine model of Lafora disease led to inhibition of further accumulation of Lafora bodies in older mice that had already formed bodies and prevented Lafora body formation in young mice that had not yet formed any (87). This evidence concerns the gene GYS1 and Lafora disease.